Hugh Moore, MD
Family Medicine · Koloa, HINPI 1316033574
Payments from drug & device makers
What this record shows
Novartis accounts for 77.4% of it on its own, with 12 other manufacturers making up the rest. 2023 is the largest year on record at $1,130, more than ten times the $62 reported in 2019.
Across 39 payments — averaging $51.94 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Novartis$2K
- Abbott$137
- Johnson & Johnson$85
- AbbVie$78
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$38
- Sanofi-aventis U.S. LLC$24
- plus $96 from 7 others
Across 13 payments — averaging $18,110 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Novartis$235K
What the payments were for
- Travel & lodging$95947%
- Food & beverage$1,06753%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Novartis | 10 | $1,568 |
| Abbott | 8 | $137 |
| Johnson & Johnson | 6 | $85 |
| AbbVie(2 entities) | 4 | $78 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 3 | $38 |
| Sanofi-aventis U.S. LLC | 1 | $24 |
| Pfizer | 1 | $19 |
| Boehringer Ingelheim | 1 | $17 |
| Hikma Pharmaceuticals USA | 1 | $13 |
| Sanofi Pasteur Inc. | 1 | $12 |
| GSK | 1 | $12 |
| AstraZeneca | 1 | $12 |
| Boston Scientific | 1 | $11 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- LEQVIO$1,038
How this compares
$2,026 in reported general payments places this provider in the 80th percentile of 376 family medicine providers in Hawaii.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| JardianceEmpagliflozin | 37 | $52,626 |
| TrulicityDulaglutide | 29 | $37,658 |
| EliquisApixaban | 38 | $33,992 |
| XareltoRivaroxaban | 15 | $21,191 |
| OzempicSemaglutide | 16 | $15,308 |
| JanuviaSitagliptin Phosphate | 12 | $12,843 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 14 | $9,258 |
| Breztri AerosphereBudesonide/Glycopyr/Formoterol | 12 | $7,245 |
| Atorvastatin Calcium | 320 | $5,900 |
| Losartan Potassium | 238 | $4,291 |
| Wixela InhubFluticasone Propion/Salmeterol | 21 | $2,236 |
| Lantus SolostarInsulin Glargine,hum.Rec.Anlog | 24 | $2,174 |
| Rosuvastatin Calcium | 98 | $2,159 |
| Metoprolol Succinate | 115 | $2,146 |
| Amlodipine Besylate | 234 | $2,050 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| Boehringer IngelheimJardiance | $17 | $52,62637 claims |
| PfizerEliquis | $19 | $33,99238 claims |
| Johnson & JohnsonXarelto | $85 | $21,19115 claims |
| GSKTrelegy Ellipta | $12 | $9,25814 claims |
| AstraZenecaBreztri Aerosphere | $12 | $7,24512 claims |
| AbbVieSynthroid | $78 | $72111 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 376 family medicine providers in Hawaii.
Other family medicine in Koloa
- Brian StolleyKihei$126K
- Vicente RamoHonolulu$34K
- Edward AlqueroWaipahu$24K
- Noelani HobbsWaipahu$23K
- Rainier Dennis BautistaLihue$23K
- Choon YeoHonolulu$20K
- Buddy FesterlingHilo$20K
- Roy KogaHilo$20K
- Stuart LernerKailua$18K
- Johanna Christa JavierKapolei$17K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.